Horizon Therapeutics Senior Software Engineer Salaries in Corvallis, OR
The average Horizon Therapeutics Senior Software Engineer in Corvallis, OR earns an estimated $149,198 annually, which includes an estimated base salary of $131,409 with a $17,789 bonus. Horizon Therapeutics' Senior Software Engineer compensation is $11,603 more than the US average for a Senior Software Engineer. Senior Software Engineer salaries at Horizon Therapeutics in Corvallis, OR can range from $67,000 - $298,000.
In Corvallis, OR, The Engineering Department at Horizon Therapeutics earns $11,698 more on average than the Marketing Department.
Last updated 3 years ago.
- $131,409
- avg. base
- $17,789
- avg. bonus
Senior Software Engineer Salaries at Horizon Therapeutics
In Corvallis, OR, Senior Software Engineers earn $5,593 more than Lead Engineers, and $7,982 less than Principal Engineers.
Compensation at Horizon Therapeutics by Department
In Corvallis, OR, The Engineering Department averages $11,698 more than the Marketing Department, and $22 less than the Operations Department
Senior Software Engineer Compensation by Gender (All Companies)
The average female Senior Software Engineer at companies similar size to Horizon Therapeutics reported making $138,171, while the average male Senior Software Engineer at similar sized companies reported making $151,379.
Senior Software Engineer Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Senior Software Engineer at companies similar size to Horizon Therapeutics reported making $152,772, while the average Choose not to identify Senior Software Engineer at similar sized companies reported making $81,000.
How Senior Software Engineers at Horizon Therapeutics Rate Their Compensation
The majority of Senior Software Engineers at Horizon Therapeutics believe they're compensated fairly. 100% of Senior Software Engineers at Horizon Therapeutics say they receive annual bonuses, and the vast majority (78%) are satisfied with their benefits. See more compensation ratings at Horizon Therapeutics
